EYEBROM

Bromfenac

Composition : Each ml ophthalmic solution contains Bromfenac 0.9mg as Bromfenac sodium INN.

Indication : Bromfenac ophthalmic solution is indicated for treatment of postoperative inflammation and in patients who have undergone cataract extraction, prevention of miosis in cataract surgery, treatment of pseudophakic cystoid macular edema (CME), treatment of external anterior ocular inflammatory diseases such as blepharitis, conjunctivitis and scleritis.

Dosage and administration : For the treatment of postoperative inflammation and in patients who have undergone cataract extraction, one drop of Bromfenac ophthalmic solution should be applied to the affected eye (s) two times daily beginning 24 hours after cataract surgery and continuing through the first two weeks of the postoperative period. Prevention of miosis in cataract surgery: beginning 1 hour prior to surgery, instill bromfenac every 30 minutes. Treatment of pseudophakic CME: 1 drop 2 times daily for 3 months. Or, as directed by the registered physician.

Use in pregnancy and lactation : There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. Caution should be exercised when bromfenac ophthalmic solution is administered to a nursing women.

Packing: 5ml in plastic dropper bottle.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2022 Designed and Developed by ATI Limited.